Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Connected Injectable Drug Delivery Devices Market - Forecast (2017-2023) - Research and Markets

Research and Markets
Posted on: 20 Nov 17

The "Connected Injectable Drug Delivery Devices Market: By Device Type; By Technology; By Application; By End User & By Geography - Forecast (2017-2023)" report has been added to Research and Markets' offering.

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition. These drug delivery devices helps in addressing the patient consistence issues with the medication treatment, disease management protocols which are major concerns for healthcare professionals and pharmaceutical industry. Before bringing a connected health offering to life, it is important to understand the fundamentals of patient-centric design. One of the most successful elements in fulfilling the need for patient-centric design is human factors analysis, which benefits the patient by making injection systems more comfortable and user-friendly.

Connected injectable drug delivery devices market is comprehended by device type, technology, application and end user. By device type the market is further segmented into inhalation devices, injection devices, solid dosage forms and others. Whereas injection devices are further sub segmented into handheld devices and wearable devices. Based on technology the market is categorized into Bluetooth, smart phone apps, near field communication (NFC) and emergency technologies. By application the market is further segmented into diabetes, cardiovascular diseases, autoimmune diseases, hormones replacement, neurology, addiction, respiratory diseases and others. Based on end users the market is categorized into hospitals, clinics and homecare settings.

Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of these devices. Increased interest of pharmaceutical or medical devices companies to surge consumer compatibility and application is expected to propel the growth of the market in the near future.

Companies Mentioned

  • Phillips-Medisize Corporation
  • West Pharmaceutical Services, Inc.
  • Biocorp
  • Aterica, Inc.
  • Unilife Corporation
  • Panasonic Corporation
  • Propeller Health
  • Qualcomm Technologies, Inc.
  • Haselmeier
  • SHL Group

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Connected Injectable Drug Delivery Devices Market - By Device Type

7. Connected Injectable Drug Delivery Devices Market - By Technology

8. Connected Injectable Drug Delivery Devices Market - By Application

9. Connected Injectable Drug Delivery Devices Market - By End User

10. Connected Injectable Drug Delivery Devices Market - By Geography

11. Market Entropy

12. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/bxrtrk/connected

View source version on businesswire.com: http://www.businesswire.com/news/home/20171120005701/en/

Business Wire
www.businesswire.com

Last updated on: 20/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.